FCCC LOGO Faculty Publications
Gupta V , Tallman MS , He WS , Logan BR , Copelan E , Gale RP , Khoury HJ , Klumpp T , Koreth J , Lazarus HM , Marks DI , Martino R , Rizzieri DA , Rowe JM , Sabloff M , Waller EK , DiPersio JF , Bunjes DW , Weisdorf DJ
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
Blood. 2010 Sep;116(11) :1839-1848
PMCID: PMC3173984   
Back to previous list
Abstract
We compared the outcomes of unrelated donor (URD, n = 358) with human leukocyte antigen (HLA)-matched sibling donor (MSD, n = 226) transplantations in patients with acute myeloid leukemia (AML) in first complete remission (CR1) having unfavorable cytogenetics at diagnosis. Unfavorable cytogenetic abnormalities were: complex (>= 3 abnormalities), 32%; and noncomplex involving chromosome 7, 25%; chromosome 5, 9%; 11q or MLL rearrangements, 18%; t(6; 9), 5%; and other noncomplex, 10%. URDs were HLA-well-matched (n = 254; 71%) or partially-matched (n = 104; 29%). Three-year leukemia-free survival (LFS) for MSD was 42% (95% confidence interval [CI], 35%-48%) compared with 34% (95% CI, 28%-41%) for HLA-well-matched URD and 29%(95% CI, 20%-39%) for partially-matched URD (P=.08). In multivariate analysis, HLA-well-matched URD and MSD yielded similar LFS (relative risk [RR] = 1.1, 95% CI, 0.86-1.40, P=.44) and overall survival (OS; RR = 1.06, 95% CI, 0.83-1.37, P=.63). LFS and OS were significantly inferior for HLA-partially-matched URD recipients, those with prior myelodysplastic syndrome, and those older than 50 years. All cytogenetic cohorts had similar outcomes. Patients with chronic graft-versus-host disease had a significantly lower risk of relapse (RR = 0.68, 95% CI, 0.47-0.99, P=.05). Hematopoietic cell transplantation (HCT) using HLA-well-matched URD and MSD resulted in similar LFS and OS in AML patients in CR1 with unfavorable cytogenetics. Outcomes of HCT from HLA-partially-matched URD were inferior. (Blood. 2010; 116(11): 1839-1848)
Notes
Gupta, Vikas Tallman, Martin S. He, Wensheng Logan, Brent R. Copelan, Edward Gale, Robert Peter Khoury, Hanna J. Klumpp, Thomas Koreth, John Lazarus, Hillard M. Marks, David I. Martino, Rodrigo Rizzieri, David A. Rowe, Jacob M. Sabloff, Mitchell Waller, Edmund K. DiPersio, John F. Bunjes, Donald W. Weisdorf, Daniel J. Amer soc hematology Washington 654et